Main markers of vascular endothelium dysfunction in primary open-angle glaucoma

Bibliography:
1. Dorofienko NN. The role of the vascular endothelium in the body and the universal mechanisms for changing its activity (literature review). Bulletin Physiology and Pathology of Respiration 2018; (68): 107-16
2. Kurysheva Nl. Vascular theory of the glaucomatous optic neuropathy pathogenesis: physiological and pathophysiological rationale: Part 2. Russian journal of glaucoma 2017; 16 (4): 98-109
3. StepanovaTV, IvanovAN, Popykhova EB.etal. Endothelial dysfunction and its markers. Eurasian scientific association 2018; 2 (45): 120-3
4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288 (5789): 373-6
5. Vyunitskaya LV. Endothelial dysfunction markers. Laboratory diagnostics: Eastern Europe 2015; 3-4 (15-16): 37-51
6. Pokrovskaya TG. Role farmacology correction of L-arginine/NO pathway in nitric oxide deficiency modelling. Kuban Scientific Medical Bulletin 2008; (4): 122-5
7. Daiber A, Steven S, Webe A, et al. Targeting vascular (endothelial) dysfunction. BrJ Pharm 2017; (174): 1591-619
8. Ziganshina MM, Sergunina OA, Nikolaeva MA, et al. Anti-endothelial antibodies — the tip of the iceberg: what is down? Uspekhi sovremennoy biologii 2017; 137 (3): 288-99
9. Vasina LV, Petrishchev NN, Vlasov TD. Markers of endothelial dysfunction. Regional blood circulation and microcirculation 2017; 16 (1): 4-15
10. Astakhov YS, Tultseva SN, Titarenko Al. The role of endothelium dysfunction in the pathogenesis of vascular ocular diseases. Regional blood circulation and microcirculation 2016; 15 (60): 5-16
11. Petrishchev NN. Endothelial dysfunction. Causes, mechanisms, pharmacological correction Saint Petersburg: SPbGMU, 2002; 184 p.
12. Angelini F, Pagano F, Bordin A. The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System. Oxid Med Cell Longev 2017; (2017): 2712751
13. Vorob'eva EN, Vorob'ev Rl, Sharlaeva EA, et al. Endothelial dysfunction in cardiovascular diseases: risk factors, methods of diagnosis and correction. Acta Biologica Sibirica 2016; 2 (1): 21-40
14. Fateeva VV, Vorob'eva OV Markers of endothelial dysfunction in chronic cerebral ischemia. S. S. Korsakov Journal of Neurology and Psychiatry 2017; (4): 107-111
15. Petrishchev NN, Vasina LV, Sapegin AA. Diagnostic value of the determination of endothelial damage factors for assessing the severity of endothelial dysfunction in acute coronary syndrome. Klinicheskaya bol'nitsa 2015; 1 (11): 41-5
16. Krasnikov AV, Shabalina AA, Shvedkov VV, et al. Diagnosis of endothelial dysfunction in migraine. Cardiovascular Therapy and Prevention 2018; (17): 45a-45b
17. Fedin Al, Starykh EV, Baranova OA, et al. Endothelial Dysfunction, Vascular Inflammation and Oxidative Stress in Patients with Chronic Cerebral Ischemia and Internal Carotid Artery Stenosis. Lechebnoe delo 2018; (1): 66-71
18. Feoktistova VS, Vavilova TV, Sirotkina OV, et al. The new approach to evaluation of dysfunction of endothelium: detection of number of circulating endothelium cells using flow cytometry technique. Russian Clinical Laboratory Diagnostics 2015; 60 (4): 23-39
19. Li С, Wu Q, Liu В, et al. Detection and Validation of Circulating Endothelial Cells, a Blood-based Diagnostic Marker of Acute Myocardial Infarction. PLoS ONE. 2013; 8 (3): e58478
20. Dausheva AH. Endotelial markers in comorbid pathology In: Materialy VII s'ezda kardiologov Sibirskogo federal'nogo okruga sovmestno s VII Vserossiyskoy nauchno-prakticheskoy konferentsiey. Omsk, 2017; p. 39-40
21. Puntmann VO. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease. Postgrad Med J 2009; 85 (1008): 538-45
22. Afonasyeva TM. Endothelial dysfunction: The availability of early diagnosis. Health & Education Millennium 2016; 18 (11): 101-4
23. Malishevskaya TN, Astakhov SYu. Reactance of vascular endothelium at elderly patients with primary open-angle glaucoma and physiologically growing old people depending on expressiveness of endothelium dysfunction. Regional blood circulation and microcirculation 2016; 15 (60): 59-67
24. Chernykh VV, Bgatova NP Lymphatic structures of the eye and uveolymphatic (metabolic) pathway of intraocular fluid outflow: Part 1. Russian journal of glaucoma 2018; 17 (1): 3-13
25. Egorov EA, Kuroyedov AV Separate clinical and epidemiological characteristics of glaucoma in the CIS and Georgia: Results of a multicentre open retrospective study (Part 2). RMJ Clinical ophthalmology 2012; (1): 19-23
26. Stevens GA, White RA, Flaxman SR, et al. Vision Loss Expert Group. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology 2013; (120): 2377-84
27. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; (121): 2081-90
28. Muratov S, Podbielski DW, Jack SM. Preference-based diseasespecific health-related quality of life instrument for glaucoma: a mixed methods study protocol. BMJ Open 2016; 8 (6):e012732
29. Quigley H, Broman A. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90 (3): 262-7. 30. Erichev VP, Kozlova IV, Makarova AS, et al. Features of systemic hemodynamics in patients with progressive primary open-angle glaucoma with compensated intraocular pressure. Glaucoma 2013; 3 (1): 20-3
31. Kang JH, Wggs JL, Rosner BA. Endothelial Nitric Oxide Synthase Gene Variants and Primary Open-Angle Glaucoma: Interactions with Hypertension, Alcohol, and Cigarette Smoking. Arch Ophthalmol 2011; 129 (6): 773-80
32. Liu CH, Su WW, Shie SS, et al. Association between peripheral vascular endothelial function and progression of open-angle glaucoma. Medicine 2016; 95 (10): 1-5, e3055
33. Kurysheva Nl, Irtegova EYu, Yasamanova AN, et al. Endothelial dysfunction and platelet hemostasis in primary open-angle glaucoma. Russian journal of glaucoma 2015; 14 (1): 27-36
34. Kurysheva Nl, Irtegova EYu, Yasamanova AN. The role of endothelial dysfunction in glaucomatous optic neuropathy progression. Russian Ophthalmological Journal 2015; 8 (2): 34-9
35. Pasechnikova NV, Mikheytseva IN, Elskiy VN. Endothelium regulation problems in pathogenesis of primary glaucoma. Russian journal of glaucoma 2014; 13 (4): 5-12
36. Korsakova NV The prymary open-angle glaucoma: modern theory of development (literature review). Advances in Gerontology 2018; 31 (1): 95-102
37. Pushpakumar S, Kundu S, Sen U. Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide. Curr Med Chem 2014; 21 (32): 3662-72
38. Ajith ТА. Ranimenonb Homocysteine in ocular diseases. Clinica ChimicaActa 2015; 450: 316-21
39. Turgut В, Kaya M, Arslan S. Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin Interv Aging 2010; 5: 133-9
40. Junemann A, Rejdak R, Hohberger B. Significance of Homocysteine in Glaucoma 2018; 235 (2): 163-74
41. Kil JS, Jeong SO, Chung HT, et al. Piceatannol attenuates homocysteine-induced endoplasmic reticulum stress and endothelial cell damage via heme oxygenase-1 expression. Amino Acids 2016; 49 (4): 735-45
42. Li J, Luo M, Xie N, et al. Curcumin protects endothelial cells against homocysteine induced injury through inhibiting inflammation. Am J Transl Res 2016; 15 (11): 4598-604
43. Hemanth KB, Reddy R. Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia. Physiol Pharmacol 2017; 95 (1): 32-42
44. Cui X, Navneet S, Wang J, et al. Analysis of MTHFR, CBS, glutathione, taurine, and hydrogen sulfide levels in retinas of hyperhomocysteinemic mice. Invest Ophthalmol Vis Sci 2017 (58): 1954-1963
45. Lipnitskaya EA, Polunina EA, Kuz'michev BYu, et al. Homocysteine and Cardiovascular Pathology. Astrakhan: AGMU, 2017; 55 p.
46. Zhongjian С, Xiaofeng Y, Hypertens С, et al. Hyperhomocysteinemia and Endothelial Dysfunction. Curr Hypertens Rev 2009; 1 (5):158-65
47. Resch H, Garhofer G, Fuchsjager-Mayri G, et al. Endothelial dysfunction in glaucoma. Acta Ophthalmol 2009; (87): 4-12
48. Cellini M, Strobbe E, Gizzi C, et al. Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma. Life Sc2012; 91 (13-14): 699-702
49. Terelak BB, Czechowicz JK Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy. Klin Oczn. 2011; 113 (7-9): 201-8
50. Mel'nikova YuS, Makarova TP Endothelial dysfunction as the key link of chronic diseases pathogenesis. Kazanskii medicinskii zhurnal 2015; 96 (4): 659-65.